Skip to content
Screener

Oshkosh OSK Access — Research And Development Expense

Other segment segments

Vocational
$7.4M-46.4%
Corporate And Other
$5M-37.5%
Transport
$4.4M+267%

Similar metrics at other companies

Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Solid Biosciences Inc. logo
SLDBInternal Research And Development Expense — Research And Development Expense
$9.06M+33.9%
Disc Medicine logo
IRONInternal Research And Development — Research And Development Expense
$11.31M+67.6%
Helios Technologies logo
HLIOUnallocated Expenses — Research And Development Expense
$0
Dianthus Therapeutics logo
DNTHDiscovery Expenses — Research And Development Expense
$1.36M+51.4%
Innoviva, Inc. logo
INVAInternal Expenses — Research And Development Expense
$2.73M+127%

Other financials

Income statement

See full
Revenue$2.9B+6.7%
Gross profit$480.3M-8.4%
Operating income$243.2M-16.6%
Net income$183.2M-10.5%
EPS (diluted)$2.92-7.6%

Balance sheet

See full
Cash & equivalents$403.6M+111%
Total debt$1.1B-26.4%
Total equity$4.5B+1.6%
Total assets$10.1B+0.4%

Cash flow

See full
Operating cash flow$374.3M+320%
CapEx$26.7M-34.2%
Free cash flow$347.6M+615%

Valuation

See full
Market cap$9.43B+7.6%
Enterprise value$10.13B+0.6%
P/E17×+3.5×
P/S0.9×0.0×

Profitability

See full
Gross margin15.9%-2.2pp
Operating margin7.5%-1.7pp
Net margin5.2%-1.0pp
FCF margin11%+5.3pp

Returns & leverage

See full
Return on equity12.4%-3.1pp
Debt / equity0.2×-0.1×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Oshkosh in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Oshkosh’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 2:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-320490
Line itemAccessVocationalTransportTotal SegmentCorporateand OtherConsolidated
Net Sales$1,373.8$966.8$536.1$2,876.7$38.4$2,915.1
Cost of sales (excluding R&D)1,113.3760.8488.62,362.732.32,395.0
Research and development23.07.44.434.85.039.8
Gross income237.5198.643.1479.21.1480.3
Employee compensation44.732.715.793.141.0134.1
Amortization of purchased intangibles4.29.413.60.814.4
Other items(a)37.035.411.684.04.688.6
Operating income$151.6$121.1$15.8$288.5$(45.3)243.2

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Oshkosh's access — research and development expense?
Oshkosh (OSK) reported access — research and development expense of $23M in Q2 2026.
How has Oshkosh's access — research and development expense changed year-over-year?
Oshkosh's access — research and development expense increased by 4.5% year-over-year, from $22M to $23M.
What is the long-term trend for Oshkosh's access — research and development expense?
Over 3 years (2022 to 2025), Oshkosh's access — research and development expense has grown at a 15.2% compound annual growth rate (CAGR), from $55.3M to $84.6M.
What does access — research and development expense mean?
This represents the costs incurred by the Access segment to develop new products, improve existing technologies, and innovate within the aerial work platform market. It is a key driver of long-term competitiveness and product differentiation.

Ask your AI about Oshkosh's access — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude